Abstract
Background: Both medicolegal disputes and the incidence of cutaneous drug eruptions are increasing in Korea. We were unable to find research that surveyed the legal disputes involving drug eruption cases.Objective: This study investigates medical litigation associated with drug eruption cases in Korea.Methods: Judicial precedents on drug eruption cases were searched using the Supreme Court of Soum Korea's Written Judgement Management System. General characteristics, results, suspected agents, and recognized negligence were analyzed.Results: From the search results, 50 cases were selected. Of these, 34 cases had severe cutaneous adverse reactions,including Stevens-Johnson syndrome/toxic epidermal necrolysis (n=25, 50.0%), and drug rash with eosinophilia and systemic symptoms syndrome (n=9, 18.0%). Antimicrobial agents (n=17, 34.0%), non-steroidal anti-inflammatory drugs (n=6, 12.0%), and anticonvulsants (n=6, 12.0%) were the most common drugs implicated. Death was reported in 15 patients (30.0%). In this sample, 22 cases (47.0%) were awarded to the plaintiff, and violation of the duty to inform patients of risks was the most common legal issue cited.Conclusion: Clinicians should be aware of and advise patients of the potential for severe adverse reactions that can lead to negative outcomes and medicolegal disputes.
Original language | English |
---|---|
Pages (from-to) | 162-169 |
Number of pages | 8 |
Journal | Korean Journal of Dermatology |
Volume | 61 |
Issue number | 3 |
State | Published - Mar 2023 |
Bibliographical note
Publisher Copyright:© 2023 Korean Dermatological Association. All rights reserved.
Keywords
- Adverse drug reaction
- Drug eruptions
- Jurisprudence
- Malpractice